The largest database of trusted experimental protocols

3 protocols using malonate

1

Isogenic E. coli Strain Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isogenic E. coli K-12 strains (see Table S1 in the supplemental material) were obtained from the Keio collection (52 (link)) or constructed using CRISPR genome editing technology (53 (link)). Plasmids and primers used for this work are listed in Table S4. E. coli strains were cultured by shaking at 200 rpm aerobically at 37°C in Luria-Bertani (LB) broth or by plating on LB agar incubated at 37°C. Yeast extract, tryptone, agar, and 5(6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) were obtained from Thermo Fisher Scientific Corp. (Waltham, MA, USA). Ciprofloxacin, ampicillin, and kanamycin were obtained from Sigma-Aldrich Corp. (St. Louis, MO, USA). Vancomycin, erythromycin, lysine monohydrochloride, arginine hydrochloride, histidine hydrochloride, malonate, propidium iodide, proteinase K solution, 5× protein loading dye, dimethyl sulfoxide (DMSO), and 2.2′-bipyridyl were purchased from Sangon Biotech Inc. (Shanghai, China). Lipopolysaccharide (LPS) was bought from Beyotime Biotech Inc. (Jiangsu, China). Ceftriaxone (Roche, Shanghai, China), and meropenem (Shenghuaxi Pharmaceutical Co., Chongqing, China) were gifts from the Zhongshan Hospital (Xiamen, China) pharmacy.
+ Open protocol
+ Expand
2

Antibiotic Bactericidal Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic bactericidal assay was performed as previously described.22 (link) In brief, VA-S, VA-RCAZ, ATCC33787, ΔnqrA, and ΔnqrF were cultured for 12 hours at 30°C. Samples were harvested at 8,000 rpm for 3 minutes, and washed three times with 30 mL sterile saline and resuspended in M9 minimal medium with NaAc (10 mM), MgSO4 (2 mM), and CaCl2 (0.1 mM) to 0.6 at OD600. Indicated concentrations of CAZ with or without furfual, malonate, NaN3, CCCP, or triclosan were added in a final volume of 5 mL. After incubation at 30°C for 6 hours, 100 µL aliquot samples were collected, serially diluted, and plated (10 µL aliquots) on LB medium containing 2.5% agar. The plates were cultured at 30°C for 8–10 hours. Only those dilutions generating 20–200 clones were counted to calculate CFU. Percent survival was determined by dividing the CFU obtained from a treated sample by the CFU obtained from control. For fatty acid-enabled killing of VA-S by CAZ, the bacteria were cultured in LB with 0.2 mM of palmitate or stearate for 12 hours. The collected cells were used for the antibiotic bactericidal assay described above. Furfual, malonate, triclosan palmitate, and stearate were purchased from Sangon Biotech, and Sigma-Aldrich provided NaN3 and CCCP. Experiments were repeated in three independent biologic replicates.
+ Open protocol
+ Expand
3

Evaluating Antibiotic Susceptibility of V. alginolyticus

Check if the same lab product or an alternative is used in the 5 most similar protocols
V. alginolyticus ATCC 33787 was grown at 30°C in Luria–Bertani (LB) broth (pH 7.0) supplemented with 3% sodium chloride. The overnight culture was diluted 1:100 (v/v) in fresh LB broth (supplemented with 0, 0.3, or 0.5 μg/ml OFX) at 30°C for 2 h. The bacteria were harvested by centrifugation at 8,000 rpm for 3 min, and the cells were washed and resuspended in sterile saline and adjusted to an optical density (OD600) of 1.0. To build a growth curve, the bacterial growth was examined by measuring the OD600 of the culture at the indicated time. To study the effect of antibiotics, inhibitors of pyruvate cycle, or fatty acid biosynthesis on bacterial growth, the bacterial growth was examined by measuring the OD600 of the bacterial cultures at 10 h in medium with OFX, malonate, or triclosan (Sangon Biotech, Shanghai, China). At least three biologic replicates were performed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!